Wall Street Beat
ViewRay registers for initial public offering worth up to $69 million | Medtech Wall Street news for the week of February 23, 2015
Cutera expands stock buyback to $40M
ViewRay registers for $69m IPO
ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously."
Bellerophon prices $60m IPO low, issues more shares
Zimmer revises Biomet bid for EU regulators
Boston Scientific’s Q4 profits slide 19%
(Reuters) — Medical device maker Boston Scientific (NYSE:BSX) posted a 19% fall in fourth-quarter profit as litigation charges more than doubled.
Stryker cuts the ribbon on European HQ
Baxter bests expectations with Q4 sales, earnings
Regulators deal Wright Medical a double whammy
Intuitive Surgical OKs $1B share buyback
Intuitive Surgical (NSDQ:ISRG) said today that its board approved a share repurchasing program worth up to $1 billion.